Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Implantica announces another landmark real-world RefluxStop™ study demonstrating excellent outcomes published in a prestigious top-tier journal

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces another key milestone with an independent study demonstrating robust safety and significant improvement in GERD symptoms after the RefluxStop™ procedure published in Swiss Medical Weekly , a prestigious top-tier journal.The leading GERD researchers at Hirslanden Klinik Beau-Site Hospital in Bern, Switzerland, conducted an independent study of the first 40 RefluxStop™ procedures performed by Dr. med. Joerg Zehetner (Prof.

Fortum January–June 2024 Half-year Financial Report: Resilient performance in Nordic power generation despite seasonally lower prices

FORTUM CORPORATION HALF-YEAR FINANCIAL REPORT 15 AUGUST 2024 AT 9:00 EEST This release is a summary of Fortum’s January–June 2024 Half-year Financial Report. The complete report is attached to this release as a PDF file. It is also available on the company's website at www.fortum.com/investors Resilient performance in Nordic power generation despite seasonally lower prices April–June 2024 ·Comparable EBITDA was EUR 326 (344) million. ·Comparable operating profit was EUR 233 (262) million. ·Operating profit was EUR 240 (267) million. Items affecting

R&D Update

15 August 2024   Quantum Blockchain Technologies Plc (“QBT” or “the Company”)     R&D and Business Update   Quantum Blockchain Technologies (AIM: QBT), the AIM-listed investment company focusing on a R&D and investment programme within blockchain technology, is pleased to provide an update of its recent R&D activities for the development of its disruptive Bitcoin mining technologies.   Overview The R&D activity during the past four months has been focused on two main directions:         Further improvement in the results obtained in the laboratory for

Q2 increase of 110% year over year in customer invoicing

Q2 increase of 110% year over year in customer invoicing   The CEO comments on Q2 2024:   In Q2 and with the investments made in previous quarters into our sales and marketing organization we are seeing very strong YoY increase in invoicing with existing customer support contract renewals and large project sales   With the closing of the Ultinous Zrt acquisition, we leap forward in our plans to grow our software sales thru enabling Irisity’s AI solutions, products and services with generative AI capabilities. Additional quarterly highlights included: · Irisity AB (

FlexQube receives AMR order worth approximately 1.2 million SEK

FlexQube has received a follow-up order from a global commercial vehicle manufacturer* in Sweden for the AMR system FlexQube Navigator (autonomous mobile robot). The order value amounts to approximately 1.2 million SEK, with the commercial vehicle manufacturer utilizing an option to expand the initial order. The order will be delivered during the second half of 2024.CEO Mårten Frostne comments:“I am very pleased that this global commercial vehicle manufacturer* chosen to exercise its option and place a follow-up order for the system that was previously ordered and for which we

Panoro Energy – Invitation to Half Year 2024 Results Presentation

Oslo, 15 August 2024 - The Half Year 2024 Report to be announced on Thursday 22 August will be available on our website http://www.panoroenergy.com at 07:00 a.m. CEST. The company will hold a live webinar presentation at 09:00 a.m. CEST on Thursday 22 August 2024, during which management will discuss the results and operations, followed by a Q&A session. The webinar presentation can be accessed through registering at the link below and the online event will be equipped with features to ask live questions. Joining instructions for participating online or through using local dial-in

Fondia Plc: Half-yearly Financial Report for January–June 2024 will be published on 22.8.2024 – welcome to an investor call

Fondia Plc   Press release  15.8.2024 at 8.30 a.m. EEST   Fondia Plc will publish the Half-yearly Financial Report for January–June 2024 on Thursday August 22, 2024, at approximately 8.30 a.m. EEST. The company release on the Half-yearly Financial Report will available after publishing on the company’s website https://investors.fondia.com/fi/en/releases-and-publications/reports-and-presentations.  An investor call will be held on the same day at 10.00 a.m. EEST. The investor call will be held in Finnish and can be accessed online by registering at the address https://fondia.

Checkin.com Group Quarterly Report Q2 2024

Checkin.com Group (STO:CHECK) reports continued weak travel volumes during Q2 but breakthrough in fintech after the quarter. The report in brief:Q2 2024 (vs Q2 2023): · Net revenue decreased to KSEK 20,385 (21,010) which corresponds to a growth of -3 (19)%, of which -3 (19)% was organic. · Gross profit for the period amounted to KSEK 15,312 (17,043) with a margin of 75 (81)%. · EBITDA for the period amounted to KSEK 2,661 (4,317) with a margin of 13 (21)%. · Cash flow from operating activities amounted to KSEK 2,217 (-2,180). · Net Revenue Retention LTM amounted to 103 (

Interim report 1 January – 30 June 2024

Q2 2024: Continued strength in the USSECOND QUARTER 2024 · Revenue increased by 62% to SEK 1,095m (674) · Operating profit increased by 63% to SEK -4m (-10) · Operating margin increased to -0.3% (-1.5) · The result for the period decreased by -226% to SEK -81m (64) · Basic earnings per share[1] amounted to SEK -5.56 (4.41) · Cash flows from operating activities amounted to SEK 270m (40) JANUARY - JUNE 2024 · Revenue increased by 74% to SEK 2,267m (1,305) · Operating profit increased by 169% to SEK 17m (-25) · Operating margin increased to 0.7% (-1.9) ·

Rugvista Group AB (publ) – publishes Interim Report for January–June 2024

Continued order growth in a challenging market Second quarter · Net revenue was SEK 128.4 (129.1) million, corresponding to a decrease of -0.5% (6.5%). · Organic net revenue growth was -1.0% (-1.5%). · The gross margin amounted to 63.0% (63.6%). · Operating profit amounted to SEK 2.4 (11.8) million, and the operating margin was 1.8% (9.1%). · Profit for the period amounted to SEK 2.6 (10.2) million. · Earnings per share before and after dilution amounted to SEK 0.12 (0.49). · The average NPS (Net Promoter Score) was 62 (65), and the average Trustpilot score was 4.7

Skanska builds new office building in Cincinnati, Ohio, USA, for USD 164M, about SEK 1.7 billion

Skanska has signed a contract with Medpace, a clinical research company, for the construction of a new office building in Cincinnati, Ohio, USA. The contract is worth USD 164M, about SEK 1.7 billion, which will be included in the US order bookings for the third quarter 2024.The project involves constructing a new 52,200 square meter (562,000-SF), nine-story building featuring a six-story office tower atop a three-floor parking garage and conference center. The office building will be built on the existing Medpace campus, where Skanska has successfully completed several projects.

Strong revenue growth, improved margins and positive cash flow

Readly International AB (publ) reports a second quarter where revenues increased by 14.2 per cent year-over-year to SEK 188.0 million (164.7), mainly due to well-received price increases in Germany and Sweden. Adjusted for VAT, currency effects and divestments, revenue growth was 17.6 per cent. During the same period, ARPU rose to SEK 137 (115). Gross profit was SEK 75.5 million (63.4) corresponding to a gross margin of 40.1 per cent (38.5). Adjusted EBITDA margin was positive for the fourth consecutive quarter and at a record high 8.9 (-0.9) per cent. The divestment of Readly France SA in

Lea bank ASA reports Q2 and update on the redomiciliation project

Lea bank ASA reported a profit before tax of NOK 23,7 million for Q2 2024. Gross loans amounted to 7,212.8 MNOK. Equity at the end of the quarter was NOK 1,441.8 million. Highlights of Q2 2024: - Profit before tax NOK 23,7 million (after tax NOK 19.2 million) - Net interest income of NOK 138.7 million - Gross loan portfolio of NOK 7.2 billion - Cost-income ratio (C/I) of 30,6% - Book value per share of NOK 14.54 Group consolidated accounts (included Swedish subsidiaries) Profit before tax for Q2 2024 of NOK 20.8 million, and Profit after tax of NOK 16.3 million.

Veidekke: Has completed the Euromining acquisition

Veidekke has completed the acquisition of Euromining in Gällivare, Sweden. Euromining, a heavy-equipment contractor that mainly targets the mining industry, will strengthen Veidekke's operations in northern Sweden, which currently focuses on new construction of infrastructure and mining projects.After a letter of intent announcing the acquisition was published 20 May 2024, due diligence has been completed, and the parties have signed final agreements. “The Euromining acquisition strengthens Veidekke's position in a region boasting considerable activity and exciting prospects. Euromining

NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT

Press release Nanoform Finland Plc August 15, 2024 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Nanoform COLLABORATES WITH TAKEDA on THEIR PLASMA-DERIVED Therapy Development Helsinki, Finland – August 15, 2024 - Nanoform Finland Plc (“Nanoform”), the medicine performance-enhancing company, today announced that it is to enter into a pre-clinical development agreement with the Plasma-derived Therapies Business Unit of Takeda Pharmaceuticals, Inc., the R&D-driven biopharmaceutical company headquartered in Japan, to develop innovative plasma-derived therapy formulations for

Pioneering study identifies six genetic regions associated with normal pressure hydrocephalus

A new study by the University of Eastern Finland and partners identified new genetic variants associated with normal pressure hydrocephalus (NPH). Published in Neurology, the study is the first large-scale genome-wide association study related to NPH in the world. The results provide new insights into the genetic background of NPH and provide a basis for further research into the specific biological mechanisms underlying the condition.NPH is a chronic neurological syndrome in the elderly that affects gait, memory and bladder control. The current treatment for NPH is shunt surgery. The

INTERIM REPORT FOR THE SECOND QUARTER 2024NEW WAVE GROUP AB

PERIOD 1 APRIL – 30 JUNE 2024 · Net sales amounted to SEK 2,397.9 million, which was 4% higher than last year (SEK 2,304.5 million). Currency changes affected net sales positively by 1%. · Operating result amounted to SEK 301.2 (363.9) million. · Result for the period amounted to SEK 210.3 (259.6) million. · Earnings per share amounted to SEK 1.59 (1.96). · Cash flow from operating activities amounted to SEK 337.5 (230.1) million. PERIOD 1 JANUARY – 30 JUNE 2024 · Net sales amounted to SEK 4,393.1 million, which was 1% lower than last year (SEK 4,440.0 million).

poLight ASA – continues to improve its position in the AR/MR market

KEY EVENTS in the quarter · Design-win with Vuzix Shield industrial AR smart glasses. · Purchase order received for TWedge® wobulator evaluation kits and samples from major consumer AR/MR original equipment manufacturers (OEM) customers. · Wooptix announced a wavefront phase camera, the SEBI RT1000, using TLens®. · New purchase order received worth NOK 600,000 supporting the barcode scanning market. · Rights issue resulted in approximately NOK 124 million in net proceeds to the company. · Employed new CFO, Rolf Joakim Hines Bredahl. · Successfully held Capital Market

Veidekke: Q2 2024 results

Veidekke achieved revenues of NOK 10.8 billion in Q2, and a profit before tax of NOK 484 million. The group’s order book totalled NOK 41.1 billion at quarter-end. The profit per share was NOK 2.7.“Veidekke maintained a high level of activity and delivered a year-on-year improvement in both profits and profitability,” says Group CEO Jimmy Bengtsson. “Our operations are solid, and even with somewhat lower earnings, we improved our profits significantly compared to the second quarter of last year. Infrastructure Norway made the greatest progress, and I am particularly pleased about the

Kojamo plc Half-Year Financial Report 1 January–30 June 2024

Kojamo plc Stock Exchange Release, 15 August 2024 at 8.00 a.m. EESTKojamo plc Half-Year Financial Report 1 January–30 June 2024 Total revenue and net rental income increased, renting was impacted by the continued abundant supply on the market This is a summary of the January–June Half-Year Financial Report, which is in its entirety attached to this release and can be downloaded from the company’s website at www.kojamo.fi/investors. Unless otherwise stated, the comparison figures in brackets refer to the corresponding period of the previous year. The figures in this Half-Year

Bioretec Ltd’s half-year report January–June 2024: RemeOs™ trauma screw controlled launch in the U.S. yielded expected positive clinical results

Bioretec Ltd  Company announcement 15 August 2024 at 8:00 a.m.This announcement is a summary of Bioretec Ltd’s half-year report January–June 2024. The complete half-year report with tables is attached to this release as a pdf file and available at the company’s web pages at https://bioretec.com/investors/investors-in-english/releases.   April–June 2024 in brief · Net sales increased by 68% and amounted to EUR 1,379 thousand (4–6/2023: EUR 820 thousand). · Sales margin (excl. other income) was EUR 1,033 (609) thousand, or 74.9% (74.3%) of net sales. · Profit (loss) for the

Interim report Q2 2024

”In the second quarter, net sales reached SEK 9,243 million (9,462). Adjusted EBITA was SEK 894 million (922), with an adjusted EBITA margin of 9.7 percent (9.7). Cash flow, organic profit growth and profitability remain our top priorities. In the quarter, this was reflected in a cash conversion rate of 101 percent (LTM) and an EBITA margin in line with last year. Once we start to deliver organic profit growth consistently and reduce our leverage ratio, Storskogen will be able to return to a normalised state, allowing us to allocate capital to achieve both organic and acquired profit growth”,

First day to exercise Catena Media’s warrants (CTM TO1) for subscription of new shares during 18th and final exercise period

Catena Media plc today announces that the 18th and final period to subscribe for shares in the company by exercise of warrants (ticker CTM TO1) (“the warrants”) commences today, 15 August 2024, and will run until and including 24 August 2024. During this period, each warrant entitles the holder to subscribe for one (1) new share in the company at a subscription price of SEK 18.90. Payment of subscribed shares can be made in cash or through set-off with the full nominal amount of each hybrid capital security (ticker CATME HO1) that the warrant holder uses for set-off. The nominal amount

Hexagon Composites ASA: Second quarter 2024

15 August 2024: Hexagon Composites (OSE: HEX.OL), world leader in composite cylinder technology and related systems for storage and transportation of clean gaseous energy reported revenues of NOK 1 150 million for second quarter 2024 (Q2’23: 1 161 million). The reported EBITDA was NOK 137 million (Q2’23: 110 million), resulting in a 12% EBITDA margin (Q2’23: 9%).  “The main highlight of the quarter was the substantial increase in EBITDA for the Group, reaching NOK 137 million, an improvement of 25%,” says Jon Erik Engeset, Group CEO of Hexagon Composites. “On June 3 we sold Hexagon

There are no items matching the current filter
There are no more items matching the current filter
Back to top